QQ客服 官方微博 反馈留言

	A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome
	Wang, Jianxin; Yan, Dongliang; Liang, Kuixiang; Xu, Zhonghua
刊名	INTERNATIONAL UROLOGY AND NEPHROLOGY
	2016
卷号	48期号:1页码:13-18
关键词	Prostatitis Levofloxacin Terazosin Treatment
DOI	10.1007/s11255-015-1147-1
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4713709
专题	山东大学
作者单位	1.Shandong Univ, Qilu Hosp, Dept Urol, 107 Wenhua Xi Rd, Jinan 250000, Shandong, Peoples R China. 2.Binz
推荐引用方式 GB/T 7714	Wang, Jianxin,Yan, Dongliang,Liang, Kuixiang,et al. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome[J]. INTERNATIONAL UROLOGY AND NEPHROLOGY,2016,48(1):13-18.
APA	Wang, Jianxin,Yan, Dongliang,Liang, Kuixiang,&Xu, Zhonghua.(2016).A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.INTERNATIONAL UROLOGY AND NEPHROLOGY,48(1),13-18.
MLA	Wang, Jianxin,et al."A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome".INTERNATIONAL UROLOGY AND NEPHROLOGY 48.1(2016):13-18.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。